An investigation of the dihydropyrimidinase-like 2 (DPYSL2) gene in schizophrenia: Genetic association study and expression analysis

International Journal of Neuropsychopharmacology

Volumn 9, Issue 6, 2006, Pages 705-712

  Zhao, Xinzhi ^a,b   Tang, Ruqi ^a,b   Xiao, Zeping ^c   Shi, Yongyong ^a,b   Feng, Guoying ^c   Gu, Niufan ^c   Shi, Jianguo ^d   Xing, Yangling ^d   Yan, Lijuan ^e   Sang, Hong ^e   Zhu, Shaomin ^f   Liu, Huijun ^f   Chen, Wuyan ^a,b   Liu, Jixia ^a,b   Tang, Wei ^a,b   Zhang, Jing ^a,b   He, Lin ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c SHANGHAI MENTAL HEALTH CENTER   (China)

^d Xi'an Institute of Mental Health   (China)

^e Changchun Kaixuan Hospital   (China)

^f Jilin Institute of Mental Health   (China)

Author keywords

Allele specific expression; DPYSL2; Gene expression; Genetic association; Schizophrenia

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN; DIHYDROPYRIMIDINASE; MESSENGER RNA;

ADULT; ALLELE; ARTICLE; BRAIN; CASE CONTROL STUDY; CHINESE; CHROMOSOME 8P; COMPARATIVE STUDY; CONTROLLED STUDY; DIHYDROPYRIMIDINASE LIKE 2 GENE; FEMALE; GENE; GENE EXPRESSION; GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NERVE CELL DIFFERENTIATION; NERVE FIBER; PARANOIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

ADULT; ALLELES; CHROMOSOME MAPPING; DNA, COMPLEMENTARY; EXONS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE FREQUENCY; GENOTYPE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SCHIZOPHRENIA;

EID: 33846277586     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145705006267     Document Type: Article

References (29)

1. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, et al. (1998). Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nature Genetics 20, 70-73.
2. Bray NJ, Buckland PR, Owen MJ, O'Donovan MC (2003). Cis-acting variation in the expression of a high proportion of genes in human brain. Human Genetics 113, 149-153.
3. Conne B, Stutz A, Vassalli JD (2000). The 3k′ untranslated region of messenger RNA: a molecular 'hotspot' for pathology? Nature Medine 6, 637-641.
4. Dudbridge F (2003). Pedigree disequilibrium tests for multilocus haplotypes. Genetic Epidemiology 25, 115-121.
5. Edgar PF, Douglas JE, Cooper GJ, Dean B, Kydd R, Faull RL (2000). Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Molecular Psychiatry 5, 85-90.
6. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA (2004). Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nature Genetics 36, 131-137.
7. Fukata Y, Itoh TJ, Kimura T, Menager C, Nishimura T, Shiromizu T, Watanabe H, Inagaki N, Iwamatsu A, Hotani H, Kaibuchi K (2002). CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nature Cell Biology 4, 583-591.
8. Gladkevich A, Kauffman HF, Korf J (2004). Lymphocytes as a neural probe: potential for studying psychiatric disorders. Progress in Neuropsychopharmacology and Biological Psychiatry 28, 559-576.
9. Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS, Read T, Murphy P, Blaveri E, McQuillin A, et al. (2001). Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. American Journal of Human Genetics 68, 661-673.
10. Hahn LW, Ritchie MD, Moore JH (2003). Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19, 376-382.
11. Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, Inada T, Ozaki N (2004). Association of AKT1 with schizophrenia confirmed in a Japanese population. Biological Psychiatry 56, 698-700.
12. Inagaki N, Chihara K, Arimura N, Menager C, Kawano Y, Matsuo N, Nishimura T, Amano M, Kaibuchi K (2001). CRMP-2 induces axons in cultured hippocampal neurons. Nature Neuroscience 4, 781-782.
13. Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, Shore AD, Torrey EF, Yolken RH (2000). Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Molecular Psychiatry 5, 142-149.
14. Kendler KS, Myers JM, O'Neill FA, Martin R, Murphy B, MacLean CJ, Walsh D, Straub RE (2000). Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish Study of High-Density Schizophrenia Families. American Journal of Psychiatry 157, 402-408.
15. Lewis DA, Lieberman JA (2000). Catching up on schizophrenia: natural history and neurobiology. Neuron 28, 325-334.
16. Marchini J, Donnelly P, Cardon LR (2005). Genome-wide strategies for detecting multiple loci that influence complex diseases. Nature Genetics 37, 413-417.
17. Muglia P, Vicente AM, Verga M, King N, Macciardi F, Kennedy JL (2003). Association between the BDNF gene and schizophrenia. Molecular Psychiatry 8, 146-147.
18. Nakata K, Ujike H, Sakai A, Takaki M, Imamura T, Tanaka Y, Kuroda S (2003). The human dihydropyrimidinase-related protein 2 gene on chromosome 8p21 is associated with paranoid-type schizophrenia. Biological Psychiatry 53, 571-576.
19. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P, Sinclair M, Crombie C, Walker N, St Clair DM (2005). BDNF gene is a risk factor for schizophrenia in a Scottish population. Molecular Psychiatry 10, 208-212.
20. Sham PC, Curtis D (1995). Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Annals of Human Genetics 59, 97-105.
21. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, et al. (2002). Neuregulin 1 and susceptibility to schizophrenia. American Journal of Human Genetics 71, 877-892.
22. Takahashi M, Shirakawa O, Toyooka K, Kitamura N, Hashimoto T, Maeda K, Koizumi S, Wakabayashi K, Takahashi H, Someya T, Nawa H (2000). Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Molecular Psychiatry 5, 293-300.
23. Tsuang M (2000). Schizophrenia: genes and environment. Biological Psychiatry 47, 210-220.
24. Vanhaesebroeck B, Alessi DR (2000). The PI3K-PDK1 connection: more than just a road to PKB. Biochemical Journal 346, 561-576.
25. Weinberger DR (1995). From neuropathology to neurodevelopment. Lancet 346, 552-557.
26. Yan H, Yuan W, Velculescu VE, Vogelstein B, Kinzler KW (2002). Allelic variation in human gene expression. Science 297, 1143.
27. Yoshimura T, Kawano Y, Arimura N, Kawabata S, Kikuchi A, Kaibuchi K (2005). GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 120, 137-149.
28. Zapata C, Carollo C, Rodriguez S (2001). Sampling variance and distribution of the D' measure of overall gametic disequilibrium between multiallelic loci. Annals of Human Genetics 65, 395-406.
29. Zhao JH, Curtis D, Sham PC (2000). Model-free analysis and permutation tests for allelic associations. Human Heredity 50, 133-139.